Infinite 1-D M(II)-Containing Chains
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine, 2. A simi-
lar procedure was followed for the methyl derivative. Column
chromatography was carried out with a hexanes/ethyl acetate
mixture (1:4) as the eluant and the product 2 recrystallized
from ethanol/chloroform as colorless block-shaped crystals
1H), 8.21 (d, J ) 5.2 Hz, 1H), 7.20 (dd, J ) 6 Hz, J ) 2.8,
1H), 3.81 (s, 3H), 0.24 (s, 9H).
3-Methoxy-5-ethynylpyridine, 5. A mixture of 3-meth-
oxy-5-((trimethylsilanyl)ethynyl)pyridine (4.25 g, 14.9 mmol)
and potassium carbonate (3.00 g, 21.7 mmol) was stirred in
methanol (80 mL) at room temperature for 1 h. The solution
was then diluted with ethyl ether (100 mL) and washed with
water (4 × 100 mL). The solvent was removed on a rotary
evaporator and the residue chromatographed on silica with
a n-pentane/ethyl acetate (10:1) as eluant. The product 5 was
1
yielding 74%. Mp: 192-194 °C. H NMR (δH; 400 MHz,
DMSO-d6): 9.18 (d, J ) 2 Hz, 1H), 8.63 (dd, J ) 4.8 Hz,
J ) 1.6 Hz, 1H), 8.33 (dt, J ) 8 Hz, J ) 1.6 Hz, 1H), 7.48
(dd, J ) 8 Hz, J ) 4.8 Hz, J ) 0.8 Hz, 1H), 7.09 (s, 1H),
6.65 (s, 2H), 2.28 (s, 3H). 13C NMR (δC; 400 MHz, DMSO-
d6): 168.52, 163.61, 161.43, 150.88, 147.89, 134.05, 132.66,
123.64, 105.41, 23.66. IR (KBr): 3324, 3154, 1576, 1345
cm-1.
1
isolated as a white solid (1.72 g, 87%). H NMR (δH; 200
MHz, CDCl3): 8.21 (d, J ) 2.8 Hz, 1H), 8.16 (d, J ) 4 Hz,
1H), 7.15 (dd, J ) 5.8 Hz, J ) 3 Hz, 1H), 3.72 (s, 3H), 3.17
(s, 1H).
3-Methoxy-5-bromopyridine, 3. A solution of sodium
methoxide in 25% methanol (6.83 mL, 31.6 mmol) was
combined with DMF (anhydrous 20 mL) under an inert N2
atmosphere in a round-bottom flask. 3,5-Dibromopyridine
(5.00 g, 21.1 mmol) was then added and stirred at 65 °C for
24 h. An additional 1 equiv of sodium methoxide in 25%
methanol (2.33 mL) was added after 4 h. The reaction was
monitored by TLC and allowed to cool to room temperature
upon completion. The reaction was then diluted with water
(50 mL) and extracted with diethyl ether (3 × 50 mL). The
organic extractions were combined and washed with brine
and then dried over magnesium sulfate. The solvent was
removed on a rotary evaporator and the residue chromato-
graphed on silica with a hexanes/ethyl acetate mixture (1:1)
as the eluant. The product, 5-bromo-3-methoxypyridine,11
was isolated as a yellow oil. Hexanes (20 mL) was then
added to the product, and the solution was placed in the
refrigerator. Colorless crystals precipitated from the mother
liquor, which were isolated and dried (2.82 g, 71%). Mp:
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypy-
ridin-5-yl)ethyne, 6. 2-Amino-4-chloro-6-methylpyrimidine
(360 mg, 2.50 mmol), 3-methoxy-5-ethynylpyridine (400 mg,
3.01 mmol), copper(I) iodide (12.0 mg, 0.0710 mmol),
triphenylphosphine (50.0 mg, 0.191 mmol), and bis(triph-
enylphosphine)palladium(II) dichloride (50.0 mg, 0.071
mmol) were added to a round-bottom flask. Tetrahydrofuran
(12 mL) and triethylamine (12 mL) were added, and
dinitrogen was bubbled through the resultant mixture for 10
min. A condenser was attached and the mixture heated at
70 °C under a dinitrogen atmosphere. The reaction was
monitored by TLC and allowed to cool to room temperature
upon completion (48 h). The solution was then diluted with
50 mL of ethyl acetate, and the new solution was washed
with water (3 × 100 mL) and then washed with saturated
aqueous sodium chloride (1 × 100 mL). The organic layer
was separated and dried over magnesium sulfate. The solvent
was removed on a rotary evaporator and the residue
chromatographed on silica with a hexanes/ethyl acetate
mixture (1:1) as the eluant. The product 6 was isolated as a
light brown solid. The product was recrystallized from
chloroform producing colorless block-shaped crystals (426
1
27-29 °C. H NMR (δH; 400 MHz, CDCl3): 8.29 (d, J )
1.6 Hz, 1H), 8.25 (d, J ) 2.4 Hz, 1H), 7.36 (dd, J ) 2.6 Hz,
J ) 1.8 Hz, 1H), 3.86 (s, 3H). 13C NMR (δC; 400 MHz,
CDCl3): 155.83, 142.70, 136.01, 123.01, 120.18, 55.61.
3-Methoxy-5-((trimethylsilanyl)ethynyl)pyridine, 4.
3-Methoxy-5-bromopyridine (3.26 g, 17.31 mmol), (trim-
ethylsilyl)acetylene (2.05 g, 20.9 mmol), copper(I) iodide
(0.100 g, 0.590 mmol), triphenylphosphine (0.420 g, 1.60
mmol), and bis(triphenylphosphine)palladium(II) dichloride
(0.360 g, 0.510 mmol) were added to a round-bottom flask.
Tetrahydrofuran (75 mL) and triethylamine (75 mL) were
added, and dinitrogen was bubbled through the resultant
mixture for 10 min. A condenser was attached and the
mixture heated at 65 °C under a dinitrogen atmosphere. The
reaction was monitored by TLC and allowed to cool to room
temperature on completion (26 h). The solution was then
diluted with 100 mL of ethyl acetate, and the new solution
was washed with water (3 × 100 mL) and then washed with
saturated aqueous sodium chloride (1 × 100 mL). The
organic layer was separated and dried over magnesium
sulfate. The solvent was removed on a rotary evaporator and
the residue chromatographed on silica with n-pentane as the
eluant. The product 4 was isolated as a light yellow oil (4.25
g, 86%). 1H NMR (δH; 200 MHz, CDCl3): 8.27 (d, 1.6 Hz,
1
mg, 72%). Mp: 171-173 °C. H NMR (δH; 400 MHz,
CDCl3): 8.39 (d, J ) 2 Hz, 1H), 8.30 (d, J ) 2.8 Hz, 1H),
7.36 (dd, J ) 3 Hz, J ) 1.4 Hz, 1H), 6.70 (s, 1H), 5.43 (s,
2H), 3.85 (s, 3H), 2.35 (s, 3H). 13C NMR (δC; 400 MHz,
CDCl3): 168.88, 162.83, 154.99, 150.37, 144.92, 138.72,
122.61, 118.80, 113.48, 89.78, 87.66, 55.60, 23.81. IR
(KBr): 3326, 3171, 2229, 1652, 1558, 1423 cm-1.
2:1 Complex of 3-(2-Amino-4-methoxypyrimidin-6-yl)-
pyridine with Copper(II) 1,1,1,5,5,5-Hexafluoro-2,4-pen-
tanedione, 7. 3-(2-Amino-4-methoxypyrimidin-6-yl)pyridine
(13 mg, 0.060 mmol) and copper(II) 1,1,1,5,5,5-hexafluoro-
2,4-pentanedione (17 mg, 0.040 mmol) were added to a
screw cap vial along with chloroform (3 mL). The mixture
was heated gently until a clear homogeneous solution
resulted. Green prism-shaped crystals were harvested after
3 days (13 mg, 46%). Mp: 143-145 °C.
2:1 Complex of 3-(2-Amino-4-methoxypyrimidin-6-yl)-
pyridine with Cobalt(II) 1,3-Diphenyl-1,3-propanedione,
8. 3-(2-Amino-4-methoxypyrimidin-6-yl)pyridine (12 mg,
0.060 mmol) and cobalt(II) 1,3-diphenyl-1,3-propanedione
(16 mg, 0.030 mmol) were added to a screw cap vial along
with a mixture of 1,2-dichloroethane/chloroform (7:3 mL).
(11) Comins, D. L.; Killpack, M. O. J. Org. Chem. 1990, 55, 69-73.
Inorganic Chemistry, Vol. 44, No. 14, 2005 4985